Search - tctmd.com

Displaying 81 - 100 of 122

Sort: Relevancy | Date

Presentation TCT 2019

Sensing Renal Nerve Activity Before, During, and After Denervation I: Autonomix

Presenter: Robert Schwartz

September 28, 2019

Presentation TCT 2019

Clinical Context of SOLO and Future Results and Implications for Who to Treat

Presenter: Naomi Fisher

September 27, 2019

Presentation TCT 2019

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

RDN Procedure With the ReCor Paradise Technology: Anatomy, Treatment Location, Procedure Standardization and Simplicity

Presenter: Chandan Devireddy

September 27, 2019

Presentation TCT 2019

Introduction to Session

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

Alcohol-Mediated Renal Denervation: 1-Year and Final Results From the Peregrine Postmarket Study

Presenter: Felix Mahfoud

September 27, 2019

Presentation TCT 2019

The Target BP Program: Ongoing and Future Studies

Presenter: David Kandzari

September 27, 2019

Presentation TCT 2019

Clinical Evaluation: Peregrine Results to Date

Presenter: Felix Mahfoud

September 27, 2019

Presentation TCT 2019

Procedure Overview: Alcohol-mediated RDN Using the Peregrine System

Presenter: Horst Sievert

September 27, 2019

Presentation TCT 2019

Alcohol-Mediated Renal Denervation: How is it Different?

Presenter: Melvin Lobo

September 27, 2019

Presentation TCT 2019

TCT 607: Optimizing Safety and Efficacy of Lesion Formation for Percutaneous Renal Denervation: Human and Porcine Histological Analysis

Presenter: Andrew Sharp

September 25, 2019

$TCT 605: Sympathetic renal denervation in patients with refractory arterial hypertension: two-year follow-up$

Presentation TCT 2019

TCT 605: Sympathetic renal denervation in patients with refractory arterial hypertension: two-year follow-up

Presenter: Daniil Maximkin

September 25, 2019

Presentation TCT 2019

TCT 82: Long-Term Clinical Outcomes After Renal Denervation in an Asian Population: Results From the Global SYMPLICITY Registry in South Korea (GSR Korea)

Presenter: Byeong-Keuk Kim

September 25, 2019

Presentation TCT 2019

TCT 81: Quantification of Procedural and Anatomical Determinants of Multi-electrode Renal Denervation

Presenter: Abraham Tzafriri

September 25, 2019

News Daily News

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

Todd Neale

June 24, 2019

News Conference News EuroPCR 2019

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

L.A. McKeown

June 06, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

News Conference News ACC 2019

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

Michael O'Riordan

April 01, 2019

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

Advertisement

Sensing Renal Nerve Activity Before, During, and After Denervation I: Autonomix

Clinical Context of SOLO and Future Results and Implications for Who to Treat

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

RDN Procedure With the ReCor Paradise Technology: Anatomy, Treatment Location, Procedure Standardization and Simplicity

Introduction to Session

Alcohol-Mediated Renal Denervation: 1-Year and Final Results From the Peregrine Postmarket Study

The Target BP Program: Ongoing and Future Studies

Clinical Evaluation: Peregrine Results to Date

Procedure Overview: Alcohol-mediated RDN Using the Peregrine System

Alcohol-Mediated Renal Denervation: How is it Different?

TCT 607: Optimizing Safety and Efficacy of Lesion Formation for Percutaneous Renal Denervation: Human and Porcine Histological Analysis

TCT 605: Sympathetic renal denervation in patients with refractory arterial hypertension: two-year follow-up

TCT 82: Long-Term Clinical Outcomes After Renal Denervation in an Asian Population: Results From the Global SYMPLICITY Registry in South Korea (GSR Korea)

TCT 81: Quantification of Procedural and Anatomical Determinants of Multi-electrode Renal Denervation

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content